Photo: news18.com
Centre Proposes To Cancel 'Coldrif' Maker's Licence, TN Drug Body To Take Final Decision: Sources
The Centre has proposed cancelling the manufacturing licence of Coldrif syrup after reports of toxicity linked to affected children in multiple states, prompting public alerts and concerns over health safety.
- The Central Drugs Standard Control Organisation (CDSCO) has recommended revoking the manufacturing licence of Coldrif syrup due to its potential toxicity, specifically linked to diethylene glycol.
- Children from Madhya Pradesh's Chhindwara, Rajasthan, and Maharashtra have reportedly suffered adverse effects after consuming Coldrif syrup, raising alarms in other states like Kerala and Telangana.
- Tamil Nadu's Food and Drug Administration is set to finalize decisions on the Coldrif syrup's fate in light of the CDSCO's recommendations and ongoing public health concerns.
Why It Matters
This incident underscores critical issues in the pharmaceutical industry regarding product safety and regulatory oversight. The potential health risks posed by toxic substances like diethylene glycol highlight the need for stringent quality controls to protect vulnerable populations, particularly children.